Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2002 5
2003 2
2004 8
2005 4
2006 2
2007 10
2008 4
2009 4
2010 11
2011 9
2012 11
2013 7
2014 9
2015 11
2016 13
2017 10
2018 21
2019 25
2020 23
2021 18
2022 19
2023 19
2024 32
2025 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

270 results

Results by year

Filters applied: . Clear all
Page 1
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries.
Liu Z, Liu R, Gao H, Jung S, Gao X, Sun R, Liu X, Kim Y, Lee HS, Kawai Y, Nagasaki M, Umeno J, Tokunaga K, Kinouchi Y, Masamune A, Shi W, Shen C, Guo Z, Yuan K; FinnGen; International Inflammatory Bowel Disease Genetics Consortium; Chinese Inflammatory Bowel Disease Genetics Consortium; Zhu S, Li D, Liu J, Ge T, Cho J, Daly MJ, McGovern DPB, Ye BD, Song K, Kakuta Y, Li M, Huang H. Liu Z, et al. Nat Genet. 2023 May;55(5):796-806. doi: 10.1038/s41588-023-01384-0. Epub 2023 May 8. Nat Genet. 2023. PMID: 37156999 Free PMC article.
NINJ1 regulates plasma membrane fragility under mechanical strain.
Zhu Y, Xiao F, Wang Y, Wang Y, Li J, Zhong D, Huang Z, Yu M, Wang Z, Barbara J, Plunkett C, Zeng M, Song Y, Tan T, Zhang R, Xu K, Wang Z, Cai C, Guan X, Hammack S, Zhang L, Shi Z, Xiang FL, Shao F, Xu J. Zhu Y, et al. Among authors: wang y. Nature. 2025 Jun 9:10.1038/s41586-025-09222-5. doi: 10.1038/s41586-025-09222-5. Online ahead of print. Nature. 2025. PMID: 40490006 Free PMC article.
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE; VIVID Study Group. Ferrante M, et al. Lancet. 2024 Dec 14;404(10470):2423-2436. doi: 10.1016/S0140-6736(24)01762-8. Epub 2024 Nov 21. Lancet. 2024. PMID: 39581202 Clinical Trial.
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Lancet. 2025 Jan 4;405(10472):33-49. doi: 10.1016/S0140-6736(24)01927-5. Epub 2024 Dec 17. Lancet. 2025. PMID: 39706209 Clinical Trial.
NINJ1 regulates plasma membrane fragility under mechanical tension.
Zhu Y, Xiao F, Wang Y, Wang Y, Li J, Zhong D, Huang Z, Yu M, Wang Z, Barbara J, Plunkett C, Zeng M, Song Y, Wang Z, Cai C, Guan X, Hammack S, Zhang L, Shao F, Shi Z, Xiang FL, Xu J. Zhu Y, et al. Among authors: wang y. Res Sq [Preprint]. 2024 Oct 16:rs.3.rs-5237916. doi: 10.21203/rs.3.rs-5237916/v1. Res Sq. 2024. Update in: Nature. 2025 Jun 9. doi: 10.1038/s41586-025-09222-5. PMID: 39483869 Free PMC article. Updated. Preprint.
Natural course of ulcerative colitis in China: Differences from the West?
Wan J, Shen J, Zhong J, Ge W, Miao Y, Zhang X, Wen Z, Wang Y, Liang J, Wu K. Wan J, et al. Among authors: wang y. United European Gastroenterol J. 2024 Nov;12(9):1167-1178. doi: 10.1002/ueg2.12634. Epub 2024 Jul 19. United European Gastroenterol J. 2024. PMID: 39031457 Free PMC article.
270 results